These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4429949)

  • 1. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 2. Endotoxin-stimulated immune response to modified lymphoma cells.
    Prager MD; Ludden CM; Mandy WJ; Allison JP; Kitto GB
    J Natl Cancer Inst; 1975 Mar; 54(3):773-5. PubMed ID: 1168264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modulating effect of immunotherapy with modified tumor cells in transplantable lymphoma].
    Bratus' GG; Darchuk GF; Komissarenko VG; Nastenko EP
    Eksp Onkol; 1987; 9(2):36-40. PubMed ID: 3582237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunogenicity of L5178Y cells modified by different reagents].
    Gómez-Estrada H; López-de la Rosa LM; Becerril-Meza G; Arellano-Blanco J; Fernández-Quintero P
    Arch Invest Med (Mex); 1977; 8(2):113-22. PubMed ID: 410377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 11. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
    Rumi L; Colmerauer ME; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 14. Site-dependent differences in rejection of tumor cells with and without preimmunization.
    den Otter W; Runhaar BA; Ruitenbeek A; Dullens HF
    Eur J Immunol; 1974 Jun; 4(6):444-6. PubMed ID: 4471634
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies].
    Brondz BD
    Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 19. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.